Company / Operating Cash Flow per Share
Nuvation Bio Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.51
FY2025
5-year range
-$443.46 / -$0.51
FY2021-FY2025
Trend
+13.8%
vs FY2024
Sector context
#103 of 212
Health Care
What the data says
At $-0.51, Nuvation Bio Inc.'s operating cash flow per share ranks #103 of 212 in the Health Care sector. Operating Cash Flow per Share has increased for 3 consecutive years, from $-443.46 in FY2022 to $-0.51 in FY2025.
Based on SEC 10-K filings.
-0.51 in FY2025.
Improved from $-310.67 to $-0.51 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#103 of 212 in Health CareTop 49% of 212This company -$0.51 Sector average -$14.72
▼
+96.5% above sector average
Key checks
Key Insights
- Nuvation Bio Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 13.8% year-over-year.
- Ranks #103 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.51 | +13.8% |
| FY2024 | -$0.60 | +99.8% |
| FY2023 | -$310.67 | +29.9% |
| FY2022 | -$443.46 | -28.7% |
| FY2021 | -$344.59 | -91903.4% |
| FY2020 | -$0.37 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026